US FDA grants clearance for the use of Verdeca’s HB4 stress-tolerant soybeans in human food

8cbd8b5a-716e-45e1-8dc2-75e602e028c8articleimage.jpg

11 Aug 2017 --- Arcadia Biosciences Inc. and Bioceres S.A. have announced that the US Food and Drug Administration (FDA) has completed its full review of the safety evaluation for HB4 soybeans, produced by their joint venture, Verdeca. The FDA’s notice to Verdeca allows products derived from HB4 soybeans to be used commercially in human food and animal feed.

The US FDA uses its Biotechnology Notice process to review and assess safety data provided by companies developing new plant varieties using advanced breeding technologies. The data provided to the FDA is consistent with international regulatory requirements for genetically modified crops and will be used by Verdeca and its global partners for future regulatory submissions, the companies report.

Verdeca’s HB4 soybeans have undergone extensive testing, including multi-location field trials in Argentina and the US and multiple regulatory field trials. The results of these trials demonstrate that the HB4 trait can provide yield advantages under stress conditions – including drought and low-water conditions – found in several soybean production areas.

“The HB4 gene holds great promise for bringing better yield stability to agriculture in areas that experience chronic water stress problems,” says Raj Ketkar, President and CEO of Arcadia Biosciences. “Our combined efforts aim to create significant value for soybean growers by increasing the productivity and sustainability of this important protein crop in the face of global climate challenges.”

“The FDA is one of the most prestigious regulatory agencies in the world, and its opinions are of reference to regulators everywhere,” says Federico Trucco, CEO of Bioceres. “In a way, this FDA clearance testifies to the quality standards implemented in HB4 product development and safety evaluations. We hope this decision will help expedite international regulatory clearances for HB4 soybeans, and bring us closer to the much-anticipated launch of this unique technology.”

Completion of the FDA’s review is another key regulatory achievement in the approval process for Verdeca’s HB4 drought stress tolerance trait. The trait has already been approved in Argentina by the Ministry of Agriculture, Livestock and Fisheries.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

Plant-based and dairy-free: Delivering on consumer taste and texture expectations

14 Aug 2018 --- The demand for dairy-free and plant-based products is growing. However, taste continues to reign supreme as consumers want dairy-free products but without budging on flavor or texture. Such demands have led to a range of R&D moves to overcome textural, stability and flavor challenges while aiming to keep ingredient lists as short as possible. NutritionInsight speaks to suppliers on how they are responding to the ever-expanding dairy-free trend, with a focus on plant-based protein and milk options. 

Health & Nutrition News

Sleep supplement: Som Sleep granted Non-GMO project status

14 Aug 2018 --- The market for sleep supplements in the booming supplement industry is huge, with Americans spending an estimated 41 billion dollars on sleep aids in 2015 alone. Som Sleep, who offer ready-to-drink supplements Som Sleep Original and Som Sleep Zero Sugar, report that the market is increasingly demanding naturalness and announce that Som Sleep has received official Non-GMO project status.

Regulatory News

Pesticide Testing: NSF International updates dietary supplement certification standard

14 Aug 2018 --- NSF International and the NSF/ANSI 173 Joint Committee have updated the pesticide testing requirements included in NSF/ANSI 173, the only American National Standard for dietary supplements. A recent NSF study established chemical-specific pesticide limits for 185 pesticides that might be present in botanical ingredients used in dietary supplement ingredients.

Health & Nutrition News

GOS holds dietary fiber potential: FrieslandCampina eyes new applications

13 Aug 2018 --- FrieslandCampina is targeting the dietary fiber opportunity for its Galacto-Oligosaccharides (GOS). The move comes in response to the recent FDA green light on specific dietary fibers which presents new market opportunities and application areas. “There is a lot of interest in clean, green and label-friendly ingredients and fiber is one that they are looking for, but in good tasting applications. This really means a lot more flexibility for formulators to offer something that has both prebiotic and fiber benefits,” Sarah Staley of FrieslandCampina tells NutritionInsight on the topic of GOS as a trending prebiotic fiber.

Health & Nutrition News

Soy diets might increase women’s bone strength, suggests animal study

08 Aug 2018 --- Osteoporosis, decreased physical activity and weight gain are serious health concerns for postmenopausal women. Researchers from the University of Missouri now have discovered through a new animal study that soy protein found in food might counter the negative effects of menopause on bone and metabolic health. Moreover, the researchers believe that soy protein might also have positive impacts on bone strength for women who have not yet reached menopause.

More Articles
URL : http://www.nutritioninsight.com:80/news/us-fda-grants-clearance-for-the-use-of-verdecas-hb4-stress-tolerant-soybeans-in-human-food.html